Stem Cell Therapy for Rod and Cone Dystrophy in United Arab Emirates

Dystrophy arises from genetic mutations impacting the cone photoreceptor cells in the retina, with ongoing research pinpointing approximately 35 genes responsible for these changes. This genetic alteration leads to the progressive degeneration of these cells, causing a gradual loss of vision. These conditions collectively affect an estimated 1 in 20,000 to 100,000 individuals worldwide. Eye injuries are broadly classified into minor and major types, minor injuries can result from exposure to dust, soap, and smoke, among others, while major injuries typically stem from accidents involving the eye.

Offering patients the best available treatments, remedies, and medications is imperative. Given the crucial role of eyes in our daily lives and cognitive processes, preserving their health remains paramount. Although curing Rod and cone dystrophy may pose challenges or prove impossible, continuous efforts remain essential. It is the responsibility of healthcare providers to exhaust every avenue to either restore vision or explore treatments aimed at enhancing visual capabilities.

Rod and Cone Dystrophy Treatment:

Stem Cell Therapy Rod and Cone Dystrophy provides state-of-the-art facilities offering innovative treatments for Rod and Cone conditions, eliminating the necessity for seeking treatment abroad. These facilities prioritize cutting-edge technology and uphold stringent hygiene standards to ensure patients receive the utmost care.

Rod and Cone diseases progressively deteriorate vision, posing a risk of vision loss without timely intervention. Presently, definitive treatments for these genetic conditions are limited due to their direct connection to genes. However, Stem Cell Treatment emerges as a beacon of hope, aiming to regenerate and repair these affected or defective photoreceptor cells, arresting further deterioration, and fostering long-term eye health.

The approach involves utilizing Mesenchymal stem cells (MSCs) administered through a safe and highly effective route known as “Retro-bulbar” injections. This method maximizes the regeneration of flawed or damaged retinal photoreceptor cells. The Eye Stem Cell center specializes not only in Rod and Cone dystrophies but also in treating conditions like Stargardt’s/Macular Dystrophy, diabetic retinopathy, and macular degeneration, among others.

Diabetic retinopathy, a complication linked to high blood sugar levels, damages blood vessels within the retina. The Eye Stem Cell center addresses this issue, emphasizing the importance of managing blood sugar levels to mitigate such complications. By intervening at the cellular level, the Centre aims to prevent or alleviate the adverse effects of diabetic retinopathy.

The treatment protocols offered focus on regenerating photoreceptor cells, providing personalized care tailored to the patient’s health status. Stem Cell Therapy presents a potential solution by harnessing the body’s regenerative capacity to restore vision and uphold ocular health over an extended period. Through a comprehensive approach and specialized protocols, the Centre strives to combat various retinal conditions, offering hope and an improved quality of life for patients with vision-related ailments.

Stem Cell Treatment inUnited Arab Emirates holds promising prospects in addressing these conditions, seeking to restore vision by regenerating the damaged photoreceptor cells associated with Rod and Cone diseases. This treatment aims to halt further degradation of these cells, contributing to ocular health restoration and sustained eye regeneration over an extended period.